Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection

Haematologica. 2014 Nov;99(11):e235-7. doi: 10.3324/haematol.2014.111872. Epub 2014 Sep 5.

¹ Department of Medical Biotechnologies, Section of Pathology, University of Siena, Italy.
² Department of Medical Biotechnologies, Section of Pathology, University of Siena, Italy School of Biological and Chemical Sciences, Queen Mary University of London, UK.
³ Hematology Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
⁴ Department of Medical Biotechnologies, Section of Pathology, University of Siena, Italy Section of Pathology, Ospedale di Circolo di Busto Arsizio, Presidio Ospedaliero di Saronno, Varese, Italy.
⁵ Molecular Pathology Laboratory, Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School, Italy.
⁶ Department of Medical Biotechnologies, Infectious Diseases Section University of Siena, Italy.
⁷ Department of Medical Biotechnologies, Section of Pathology, University of Siena, Italy leoncinil@unisi.it.
⁸ Section of Pathology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

No abstract available

Keywords: Epstein-Barr virus; MYC expression; miRNA dysregulation; plasmablastic lymphoma; plasmacytoma.

Publication types